Article info

Download PDFPDF
Letter
Early changes in the pharmacokinetic profile of vedolizumab-treated patients with IBD may predict response after dose optimisation

Authors

  1. Correspondence to Prof Laurent Peyrin-Biroulet, Inserm U954 and Department of Gastroenterology, Nancy University Hospital, Université de Lorraine, Lorraine 54 511, France; peyrinbiroulet{at}gmail.com
View Full Text

Citation

Gouynou C, Pouillon L, Rousseau H, et al
Early changes in the pharmacokinetic profile of vedolizumab-treated patients with IBD may predict response after dose optimisation

Publication history

  • Received November 29, 2017
  • Revised December 23, 2017
  • Accepted December 29, 2017
  • First published January 13, 2018.
Online issue publication 
December 07, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.